{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:07:18Z","timestamp":1785859638366,"version":"3.56.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,1,9]]},"DOI":"10.1097\/01.aids.0000200541.40633.56","type":"journal-article","created":{"date-parts":[[2006,1,5]],"date-time":"2006-01-05T04:00:46Z","timestamp":1136433646000},"page":"233-240","source":"Crossref","is-referenced-by-count":100,"title":["Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy"],"prefix":"10.1097","volume":"20","author":[{"given":"Jeanne","family":"Serpaggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Chaix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Batisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Vallet-Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Fontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Viard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Piketty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Rouveix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rouzioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C virus prevalence among patients coinfected with human immunodeficiency virus: a cross sectional analysis of the US Adult AIDS Clinical Trails group","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection","volume":"33","author":"Monga","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R3-11-20210130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0168-8278(98)80341-3","article-title":"Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users","volume":"28","author":"Pol","year":"1998","journal-title":"J Hepatol"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C infection: a meta-analysis","volume":"33","author":"Graham","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/319273","article-title":"Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individual with hemophilia and hepatitis C virus infection","volume":"183","author":"Ragni","year":"2001","journal-title":"J Infect Dis"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(97)80001-3","article-title":"Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis","volume":"26","author":"Soto","year":"1997","journal-title":"J Hepatol"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510300409","article-title":"Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients","volume":"30","author":"Benhamou","year":"1999","journal-title":"The Multivirc group. Hepatology"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/jhep.2001.29201","article-title":"The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study","volume":"34","author":"Di Martino","year":"2001","journal-title":"Hepatology"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R10-11-20210130","first-page":"118","article-title":"Hepatitis C infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour","volume":"72","author":"Bodsworth","year":"1996","journal-title":"Genitourin Med"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0163-4453(94)91128-2","article-title":"Hepatitis C virus infection in sexually active homosexual men","volume":"29","author":"Buchbinder","year":"1994","journal-title":"J Infect"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1293.2004.00207.x","article-title":"HIV and hepatitis C coinfection within the CAESAR study","volume":"5","author":"Amin","year":"2004","journal-title":"HIV Med"},{"key":"R13-11-20210130","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/sti.79.2.160","article-title":"Absence of hepatitis C virus transmission in a prospective cohort of heterosexual discordant couples","volume":"79","author":"Marincovich","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.1840360713","article-title":"Sexual activity as a risk factor for hepatitis C","volume":"36","author":"Terrault","year":"2002","journal-title":"Hepatology"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/376639","article-title":"Association of Hepatitis C virus infection with sexual exposure in southern India","volume":"37","author":"Marx","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1128\/JCM.39.3.1204-1206.2001","article-title":"Molecular evidence of male to female sexual transmission of hepatitis C virus after vaginal and anal intercourse","volume":"39","author":"Halfon","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R17-11-20210130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/sti.2003.008532","article-title":"Increasing incidence of acute hepatitis C in HIV-positive men secondary to sexual transmission: a new epidemic?","volume":"80","author":"Browne","year":"2004","journal-title":"Sex Transm Infect"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00007435-200112000-00010","article-title":"Does HIV infection favor the sexual transmission of hepatitis C?","volume":"28","author":"Filippini","year":"2001","journal-title":"Sex Transm Dis"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1468-1293.2004.00225.x","article-title":"Acute hepatitis C in HIV-infected men who have sex with men","volume":"5","author":"Ghosn","year":"2004","journal-title":"HIV Med"},{"key":"R20-11-20210130","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C infection: host, viral and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa011232","article-title":"Treatment of acute hepatitis C with interferon alpha-2b","volume":"345","author":"Jaeckel","year":"2001","journal-title":"N Engl J Med"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.20196","article-title":"Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial","volume":"39","author":"Nomura","year":"2004","journal-title":"Hepatology"},{"key":"R23-11-20210130","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0016-5085(03)00668-1","article-title":"Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance","volume":"125","author":"Gerlach","year":"2003","journal-title":"Gastroenterology"},{"key":"R24-11-20210130","doi-asserted-by":"crossref","first-page":"277A","DOI":"10.1016\/S0270-9139(03)80293-8","article-title":"24 weeks of monotherapy with pegylated interferon alfa-2b in patients with acute hepatitis C infection","volume":"38","author":"Wiegand","year":"2003","journal-title":"Hepatology"},{"key":"R25-11-20210130","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/hep.20266","article-title":"Pegylated interferon in acute hepatitis C: relation to hepatitis C virus specific T cell Response kinetics","volume":"39","author":"Kamal","year":"2004","journal-title":"Hepatology"},{"key":"R26-11-20210130","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jhep.2004.11.021","article-title":"Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance","volume":"42","author":"Santonio","year":"2005","journal-title":"J Hepatol"},{"key":"R27-11-20210130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhep.2004.11.018","article-title":"Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with hepatitis C","volume":"42","author":"Broers","year":"2005","journal-title":"J Hepatol"},{"key":"R28-11-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2893.2005.00580.x","article-title":"Treatment of acute hepatitis C infection in HIV-Infected patients: a retrospective analysis of eleven cases","volume":"12","author":"Vogel","year":"2005","journal-title":"J Viral Hepat"},{"key":"R29-11-20210130","doi-asserted-by":"crossref","first-page":"10134","DOI":"10.1073\/pnas.91.21.10134","article-title":"Classification of hepatitis C virus based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes","volume":"91","author":"Stuyver","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"R31-11-20210130","first-page":"S3","article-title":"National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis C: 2002.","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"R32-11-20210130","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/00002030-200312050-00011","article-title":"Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France","volume":"17","author":"Chaix","year":"2003","journal-title":"AIDS"},{"key":"R33-11-20210130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<245::AID-JMV11>3.0.CO;2-G","article-title":"Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism","volume":"53","author":"Lee","year":"1997","journal-title":"J Med Virol"},{"key":"R34-11-20210130","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucl Acids Res"},{"key":"R37-11-20210130","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1086\/315396","article-title":"Virus load and risk of heterosexual transmission of human immunodeficiency virus and hepatitis C virus by men with hemophilia. The multicenter hemophilia cohort study","volume":"181","author":"Hisada","year":"2000","journal-title":"J Infect Dis"},{"key":"R39-11-20210130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jmv.10295","article-title":"Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV","volume":"69","author":"Pasquier","year":"2003","journal-title":"J Med Virol"},{"key":"R40-11-20210130","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/00002030-200211220-00014","article-title":"Increase in at-risk sexual behaviour among HIV-infected patients followed in the French PRIMO cohort","volume":"16","author":"Desquilbet","year":"2002","journal-title":"AIDS"},{"key":"R41-11-20210130","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/00002030-200104130-00026","article-title":"Syphilis and gonorrhea in Paris: the return","volume":"15","author":"Dupin","year":"2001","journal-title":"AIDS"},{"key":"R42-11-20210130","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1001\/jama.292.23.2839","article-title":"ANRS-HC02\u2013RIBAVIC study team: pegylated\u2013interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients. A randomized controlled trial","volume":"292","author":"Carrat","year":"2004","journal-title":"JAMA"},{"key":"R43-11-20210130","first-page":"231","article-title":"Etude de faisabilit\u00e9 pour la creation d'un observatoire national des sous-types du virus de l'h\u00e9patite C, Novembre 2000\u2013Avril","volume":"46","author":"Haus","year":"2002","journal-title":"Bull Epidemiol Hebdo"},{"key":"R44-11-20210130","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1046\/j.1365-2893.1999.00187.x","article-title":"Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response","volume":"6","author":"Martinot-Peignoux","year":"1999","journal-title":"J Viral Hepat"},{"key":"R45-11-20210130","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1099\/0022-1317-82-5-1001","article-title":"Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns","volume":"82","author":"Morice","year":"2001","journal-title":"J Gen Virol"},{"key":"R46-11-20210130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"R47-11-20210130","first-page":"927","article-title":"Infection with hepatitis C virus genotype 4 is associated with a poor response to interferon-alpha","volume":"135","author":"Sherman","year":"2001","journal-title":"Intern Med"},{"key":"R48-11-20210130","first-page":"364A","article-title":"Optimized virological response in patients with genotype 4 chronic hepatitis C treated with peginterferon alfa-2a (40 kD) (Pegasys) in combination with ribavirin (RBV)","volume":"36","author":"Diago","year":"2002","journal-title":"Hepatology"},{"key":"R49-11-20210130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1365-2036.2004.02208.x","article-title":"Meta-analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4","volume":"20","author":"Khuroo","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R50-11-20210130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1056\/NEJMoa040842","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV infected patients","volume":"351","author":"Torianni","year":"2004","journal-title":"N Engl J Med"},{"key":"R51-11-20210130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa032653","article-title":"Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV co-infected persons","volume":"351","author":"Chung","year":"2004","journal-title":"N Engl J Med"},{"key":"R52-11-20210130","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1097\/00002030-200409030-00003","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV\/HCV co-infected patients","volume":"18","author":"Laguno","year":"2004","journal-title":"AIDS"},{"key":"R53-11-20210130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00002030-200401020-00008","article-title":"Pegylated interferon alpha2B plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients","volume":"18","author":"Moreno","year":"2004","journal-title":"AIDS"},{"key":"R54-11-20210130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/135965350400900411","article-title":"Hepatitis C virus clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin","volume":"9","author":"Soriano","year":"2004","journal-title":"Antivir Ther"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003453-199942060-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:13:20Z","timestamp":1785856400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200601090-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,9]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000200541.40633.56","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1,9]]}}}